What it is like compared to traditional vaccines
Vaccines are classified as "polyvalent vaccines" because of the number of viruses they can prevent. In general, the higher the "number" of the vaccine, the higher the value of the vaccine and the higher the price. There are more than 40 known viruses that cause cervical cancer, including the human papillomavirus (HPV). So far, no polyvalent vaccine has been developed that can prevent all 40 HPVs. Cervarix and Gardasil, which are currently prescribed as national immunization vaccines in Korea, prevent two and four types of HPV, respectively.
Cervarix is a bivalent vaccine that protects against HPV types 16 and 18. It can prevent cervical cancer, cervical intraepithelial neoplasia, vulvar intraepithelial neoplasia, and vaginal intraepithelial neoplasia. Gardasil is a quadrivalent vaccine that prevents HPV types 6, 11, 16, and 18. Compared to Cervarix, the prevention rate of female genital diseases has increased. The advantage is that it is a vaccine that can be given to men as well. Gardasil is effective in preventing genital warts (condylomas) in men, anal cancer, and anal intraepithelial tumors.
Gardasil 9, which was launched in July last year, is effective in preventing types 31, 33, 45, 52 and 58 in addition to the four HPV types that the previous Gardasil vaccine prevented. The types of diseases that can be prevented remain the same, but the scope of prevention has been expanded from 70% to 90%. It is the most effective HPV vaccine in existence. This is thanks to the fact that it has been able to prevent HPV types 52 and 58, which are found in the second and third most common cases in Korean women. Existing quadrivalent vaccines cannot prevent viruses.
Comments (0)
There are no comments for this article. Be the first one to leave a message!